Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Incidence of Positive Severe Acute Respiratory Syndrome Coronavirus Polymerase Chain Reaction After Coronavirus Disease 2019 Vaccination With up to 8 Months of Follow-up: Real-life Data From the Capital Region of Denmark

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Anal human papillomavirus infection in kidney transplant recipients compared with immunocompetent controls

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Herpes simplex virus 2 meningitis in adults: A prospective, nationwide, population-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Perivalvular Extension of Infective Endocarditis after Transcatheter Aortic Valve Replacement

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Dentist's visits and risk of brain abscess: a nationwide, population-based case control study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Exploration of the induced cytokine responses in European Lyme neuroborreliosis: A longitudinal cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Polygenic risk score for ACE-inhibitor-associated cough based on the discovery of new genetic loci

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Markers of Kidney Function in Early Childhood and Association With Maternal Comorbidity

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Coronavirus disease 2019 (COVID-19) vaccines are implemented worldwide in efforts to curb the pandemic. This study investigates the risk of a positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcriptase polymerase chain reaction (RT-PCR) test following BNT162b2 vaccination in a large real-life population in Denmark.

METHODS: Vaccination status and positive SARS-CoV-2 RT-PCR results from adults in the Capital Region of Denmark (n = 1 549 488) were obtained from national registries. PCR testing was free and widely available. The number of positive PCR tests per individual at risk was calculated as weekly rates. Time to positive PCR test was modelled using Kaplan-Meier methods and hazard ratios (HRs) were calculated using Cox regression.

RESULTS: A total of 1 119 574 individuals received the first dose of BNT162b2 and 1 088 879 received a second dose of BNT162b2. Individuals were followed up to 8.7 months after first dose (median: 5.5 months; interquartile ratio: 4.1-8.7). Rates of PCR-confirmed SARS-CoV-2 infection 2-4 months after the second dose were 0.21, 0.33, and 0.36 per 1000 individuals per week at risk for July, August, and September, respectively. Four or more months after the second dose, the rates were 0.56, 0.76, and 0.53 per 1000 individuals per week at risk for July, August, and September, respectively. HR of SARS-CoV-2 infection after the second dose was 0.2 (95% confidence interval, .05-.48; P = .001) for individuals with 8 months' follow-up.

CONCLUSIONS: Individuals who received 2 doses of the BNT162b2 COVID-19 vaccine had a low risk of breakthrough infection after up to 8 months of follow-up. However, there was a tendency toward higher rates with longer follow-up.

Original languageEnglish
Article numberciac012
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Volume75
Issue number1
Pages (from-to)e675-e682
Number of pages8
ISSN1058-4838
DOIs
Publication statusPublished - 1 Jul 2022

Bibliographical note

© The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

    Research areas

  • 19, 2, BNT162b2, COVID, CoV, SARS, life data, real, vaccination

ID: 70643739